Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > New Investment Avian Flu - Again
View:
Post by Bigkahuna57 on Oct 15, 2024 9:45am

New Investment Avian Flu - Again

@TNickels et al,
I'm in agreement with your recent thoughts about Avian flu. IMO, the shortest amount of time to revenue is through animal applications. My expectations are to see increased attention/development to create an indication for animal(s). Government has already recognized the potential disaster, and need a virus or solution to mitigate animal-animal or animal-human transmission. Be it partnership, license agreement or partial ownership to further human studies in inhanced chemotheropy, or our NSCLC or GBM cancer applications for Ruvidar/Ruthenium. THIS IS WHAT GOVERNMENTS ARE INTENDED TO ADDRESS. Protect the citizenry. 
Bumped From 090324 - 
I can't figure out why/how Health Canada has not become involved with huge grants.  The potential to avoid catastrophy and significant human suffering is overwhelming. 

Propose a license agreement with HC for avian flu development. The poultry industry produces more than 800 million dozen eggs annually.  Turkey and chicken production is over 1.5 Billion kilos annually. There are more than 2,000 registered chicken farms and over 500 turkey farms in Canada. Ontario and Quebec both have near, or over 600 chicken farms. Sell the potential to avoid a clear catastrophy and show some public investment to protect the food supply.

Roger, please approach the appropriate government agency that regulates poultry.  

IMO.

GLTA. Regards, BK.
 
Comment by TommyNickels on Oct 15, 2024 11:30am
The idea that Theralase could get a grant from Health Canada (or similar) to pursue pandemic research is a realistic prospect. We just went through a nightmare. How can we not be Proactive? Theralase definitely needs to get a move on Toxicology studies and as much pre-clinical evidence as possible.  BTD approval is the validation we need for major investment to come in. The magic though is ...more  
Comment by TimboBaggins on Oct 15, 2024 1:05pm
Mr. White did say, regarding the bladder trial, they were hesitant to accept grants because if a company doesn't deliver on time the government can take over the operation. He might have a different view for viruse grant though. 
Comment by TommyNickels on Oct 15, 2024 1:10pm
When did Roger say this? 
Comment by TimboBaggins on Oct 15, 2024 1:35pm
  During the annual meeting. It was in response to a question being asked during the Q&A
Comment by TommyNickels on Oct 15, 2024 1:38pm
If Roger gets us BTD approval, none of thIS will matter. Investment will not be hard to find.  Thanks for the info.
Comment by Dumbeldorfwhite on Oct 16, 2024 11:01am
Heaven forbid they ever had to actually meet a deadline. We all know how much they care about hitting them
Comment by steamfitter on Oct 16, 2024 3:37pm
Hay Dumble you wern't the guy that was sued a few years ago were you. 
Comment by Bigkahuna57 on Oct 17, 2024 11:22am
Update in US. Human and animal avian flu Per the CDC as of the Octy 15th, there are 11 total human cases among dairy farm workers in CA. The US Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) data shows California’s total dairy herds effected, bringing the state’s total to 105.    The CA Dept of Public Health is concerned that the Avian flu and ...more  
Comment by Gooseybear on Oct 17, 2024 1:21pm
Handling different diseases should be based on risk management. A few avian flu vs. potential new Covid strain.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250